Anna Diaz Triola - 19 Jul 2021 Form 4 Insider Report for Entasis Therapeutics Holdings Inc.

Role
Chief Commercial Officer
Signature
Elizabeth M. Keiley as Attorney-in-Fact for Anna Diaz Triola
Issuer symbol
N/A
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
4
Filing time
20 Jul 2021, 16:06:16 UTC
Next filing
19 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETTX Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 19 Jul 2021 Common Stock 100,000 $2.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option shall vest on July 19, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.